7/30/2019 April 29, 2013 Pharmstar Website Statement - Pharmstar Has Completed All Patenting of AQUAPRIN

1/2

Request Information

To request moreinformation about Aquaprin,please complete the form

below.

your name

your email

enter request details here

SubmitSubmitSubmitSubmit

Investor Information

919 794 7000, Press Extension 5

Howard Phykitt

Mr. Phykitt has extensive experience inthe design and implementation ofpharmaceutical manufacturingproducts.

Working with companies such asMonsanto, Warner-Lambert, DurkeeFoods, Johnson & Johnson (McNeil),

American Home Products and manyother pharmaceutical companies, Mr.Phykitt has been tabbed with the bringing a litany of current name brandproducts to full production.

He began his career with Teledyne Isotopes, developing systems for thedetection of radioactivity in the late 50s. He moved into thepharmaceutical manufacturing industry in 1975, developing granulationand coating technology that is used today by companies such as Eli Lily andGlaxo Smithkline in the production of pharmaceutical products.

In 1984, Mr. Phykitt founded Granutec, Inc. where he developed fluid bedmicro-encapsulation for use in the pharmaceutical and agricultureindustries. By 1988, Granutec grew to $6 million in sales, and from thereto over $40 million in sales by 1990. In 1993, the company had grown toover $60 million in sales to companies such as Walmart, Eckerd, PerryDrug, and Rite Aid.

By 1993, Mr. Phykitt began the research and development of a safer, moreeffective delivery of aspirin products. By 1997, he had received 3 patents inthis developing, and through various vehicles and personal investment,

began perfecting the development of Aquaprin.

After over 17 years of researching, testing, patenting and developingAquaprin, he is now ready to bring his most important work to the $30billion pain management industry.

Mr. Phykitt is a member of the American Management Association withfluency in FDA regulatory affairs, quality control and manufacturing.

Mr. Phykitt attended Columbia University.

PharmstarPharmaceuticals, Inc.(PHAR) is a publiclytraded company.

Pharmstar has

completed all patentingof AQUAPRIN and thenecessary protection ofits intellectual property.

All research anddevelopment of

AQUAPRIN has beencompleted, and thecompany is preparing afull scale productionfacility at itsheadquarters in Wilson,NC, for retail marketing.

Listen to Bill Chappasinterview with CEO andChairman HowardPhykitt

Bill Chappas Interview

Home Why Aquaprin? Investor Info Contact Us Detailed Product Info Supporting Articles

Page 1 of 2Pharmstar Pharmaceuticals, Inc. The Makers of Aquaprin

4/29/2013http://www.pharmstarinc.com/investor-info.html

7/30/2019 April 29, 2013 Pharmstar Website Statement - Pharmstar Has Completed All Patenting of AQUAPRIN

2/2

Pharmstar Pharmaceuticals Inc (PHAR) Delayed

Last 0.002

Change 0.0012

% Change 37.50%

Time 15:29:48

Bid 0.00

Bid Size 0

Ask 0.00

Ask Size 0

Day Low 0.002

Day High 0.0025

Open 0.0022

Prev Close 0.0032

Volume 598,300

10D Ave Vol 1,797,086

Intraday 5 Dy 1 Mo 3 Mo 6 Mo 1 Yr 2 Yr 5 Yr

Hide Volume

PharmStar Pharmaceuticals, Inc. |3914 Airport Drive Wil son, NC 27896Telephone: 919 794 7000 | Fax: 919 794 7003 | e-mail: info@pharmstarinc.com | Sitemap

Page 2 of 2Pharmstar Pharmaceuticals, Inc. The Makers of Aquaprin

4/29/2013http://www.pharmstarinc.com/investor-info.html